Abiomed Inc (ABMD) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
Abiomed Inc   (NASDAQ: ABMD)
 

Abiomed Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABMD Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 7.16 % 1.97 % 0.42 % 5.64 %
Q / Q Revenue Growth (Q3 MRQ) -4.05 % -0.36 % -1.14 % 0.25 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 10.32 % 5.48 % 12.3 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 1.68 % 0.38 % 0.12 % 1.48 %
Revenue 5 Year Average Growth 18.3 % 7.62 % 8.94 % 9.55 %


ABMD's Growth Comparisons in II. Quarter 2022




Abiomed Inc 's 7.16% year on year top-line increase in the second quarter 2022 to 266 millions, decelerating from Abiomed Inc 's growth trends, but compares favorably to the 1.97% growth in the Medical Equipment & Supplies industry, and 0.42% growth in the Healthcare sector. Despite modest Sales rises in the Healthcare sector and in the Medical Equipment & Supplies industry, Abiomed Inc reported above average market Sales growth.

Top-line fell by -4.05% from the first quarter. Average annual sales growth for Abiomed Inc is 18.3%, while S & P 500's average yearly sales increase is 9.55%, including only Businesses with the second quarter 2022 financial results.


Growth Rates of ABMD's Income in the second quarter 2022


ABMD Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) -4.04 % -40.97 % -7.99 % -20.05 %
Sequential Operating Income Change (Q3 MRQ) -12.2 % -1.57 % 11.29 % -6.77 %
Y / Y Operating Income Growth (Q3 TTM) 74.54 % -23.98 % 8.3 % 3.5 %
Sequential Operating Income Growth (Q3 TTM) -0.95 % -13.39 % -5.64 % -5.38 %
Operating Income 5 Year Avg. Change 9.32 % -3.47 % 4.67 % 8.71 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 86.35 % -64.26 % -44.81 % -21.2 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) 94.55 % -22.86 % 44.21 % -17.26 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 78.85 % -39.55 % -16.2 % -3.14 %
Sequential Income from Cont. Ops. Change (Q3 TTM) 22.6 % -19.7 % -15.31 % -5.49 %
Income from Cont. Ops. 5 Year Avg. Change 21.24 % -1.89 % 8.32 % 11.88 %

ABMD Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 86.35 % -60.3 % -38.62 % -19.35 %
Q / Q Net Income Growth (Q3 MRQ) 94.55 % -12.22 % 61.92 % -15.62 %
Y / Y Net Income Change (Q3 TTM) 78.85 % -38.72 % -15.63 % -4.05 %
Sequential Net Income Change (Q3 TTM) 22.6 % -19.17 % -14.24 % -5.07 %
Net Income 5 Year Avg. Growth 21.24 % -2.75 % 10.49 % 3.58 %

ABMD's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 87.2 % -62.96 % -44.81 % -21.2 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) 95 % -22.31 % 44.21 % -17.26 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 78.58 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) 22.78 % - - -36.1 %
EPS from Cont. Ops. 5 Year Avg. Growth 19.91 % -12.8 % 8.32 % 11.88 %



ABMD EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 87.1 % -58.85 % -38.62 % -19.35 %
Q / Q EPS Net Growth (Q3 MRQ) 94.96 % -11.6 % 61.92 % -15.62 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - -99.83 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) 22.78 % - - -99.83 %
EPS Net 5 Year Avg. Change 20.56 % -2.75 % 10.49 % 3.58 %



Abiomed Inc showed impressive 87.1% year on year rise in the second quarter to $2.32, despite the -58.85% inMedical Equipment & Supplies industry, Healthcare sector dropped -38.62%. Despite modest earnings per share in the Medical Equipment & Supplies industry and ind the Healthcare sector, Abiomed Inc reported above average market earnings per share growth.

The bottom-line grew by 94.96% from the first quarter. Average yearly income per share growth for Abiomed Inc is 20.56%, while S & P 500's average annual income per share increase is 3.58% over the five years, including only Businesses with the second quarter 2022 earnings reports.

ABMD Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) -87.56 % -41.92 % -36.18 % -3.6 %
Sequential Free Cash Flow Change (Q3 MRQ) -89.17 % 54.2 % 23.34 % 25.82 %
Y / Y Free Cash Flow Change (Q3 TTM) -7.4 % -39.36 % -21.37 % 0.2 %
Sequential Free Cash Flow Change (Q3 TTM) -17.78 % -11.02 % -11.33 % -2.58 %
Free Cash Flow 5 Year Avg. Change 31 % -4.06 % 6.34 % -24.89 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - 327.72 % -62.95 % -
Sequential Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Sequential Net Cash Flow Change (Q3 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - - -32.87 % 34.34 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -6.1 % 4.36 % 25.53 % 0.33 %
Sequential Capital Expenditures Change (Q3 MRQ) 0 % 6.89 % 8.32 % 90.04 %
Y / Y Capital Expenditures Change (Q3 TTM) -27.56 % 11.19 % 10.68 % -0.33 %
Sequential Capital Expenditures Change (Q3 TTM) -1.25 % -0.87 % 2.21 % -1.69 %
Capital Expenditures 5 Year Avg. Change - 10.45 % 9.54 % 8.63 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.